Exploring Biosimilars: Insights from Pharmacy Benefit Managers

February 2, 2025 - 11:12

Josh Canavan, PharmD, the head of pharmacy at RazorMetrics, highlights the importance of education in understanding biosimilars. As the healthcare landscape evolves, biosimilars are becoming increasingly significant in providing effective treatment options at potentially lower costs. Canavan emphasizes that comprehensive education is essential for healthcare professionals to navigate this complex area.

He notes that pharmacy benefit managers (PBMs) play a critical role in the inclusion of biosimilars in their formularies. Before any medication, including biosimilars, is added, extensive research is conducted to ensure safety, efficacy, and cost-effectiveness. This rigorous evaluation process helps healthcare providers make informed decisions about treatment options for their patients.

Canavan recommends several key educational resources to enhance understanding of biosimilars. By fostering a deeper knowledge of these medications, healthcare professionals can better serve their patients and contribute to the overall improvement of healthcare outcomes. As the use of biosimilars continues to grow, ongoing education will be vital in maximizing their potential benefits.